Anti-CyclinB2 [X121.10]
Invented by Julian Gannon from The Francis Crick Institute
Invented at Cancer Research UK London Research Institute: Clare Hall Laboratories
- Datasheet
- References (3)
- Inventor Info
Info
Catalogue Number | 151181 |
Applications | IHC IP WB |
Antigen/Gene or Protein Targets | Cyclin B2 |
Synonyms | Cyclin B2; HsT17299 |
Reactivity | Xenopus laevis |
Relevance | Cyclins bind to and regulate the activity of the Cyclin Dependent Protein Kinases (CDKs). X121.1 may be used to immunoprecipitate active CDK1 complexes. |
Host | Mouse |
Immunogen | Xenopus laevis Cyclin B2 |
Positive Control | Xenopus laevis egg extract. |
Subclass | IgG1 |
Myeloma Used | Sp2/0-Ag14 |
Recommended Growing Conditions | DMEM + 5% FCS |
Strain | Balb/c |
Notes | Recommended concentration: 1ug/ml |
Research Area | Cell Cycle, Epigenetics & Nuclear Signalling |
References: 3 entries
Integrative module analysis of HCC gene expression landscapes; Li et al. 2020. Exp Ther Med. 19(3):1779-1788. PMID: 32104233.
WB
Identification of the nuclear localization signal in Xenopus cyclin E and analysis of its role in replication and mitosis.
Europe PMC ID: 12475960
Activation of Xenopus eggs by the kinase inhibitor 6-DMAP suggests a differential regulation of cyclin B and p39(mos) proteolysis.
Europe PMC ID: 10585264
Add a reference
References: 3 entries
Integrative module analysis of HCC gene expression landscapes; Li et al. 2020. Exp Ther Med. 19(3):1779-1788. PMID: 32104233.
WB
Identification of the nuclear localization signal in Xenopus cyclin E and analysis of its role in replication and mitosis.
Activation of Xenopus eggs by the kinase inhibitor 6-DMAP suggests a differential regulation of cyclin B and p39(mos) proteolysis.
Add a reference